A new product has hit the market from one of the most scientific, clean skincare companies. Hydrinity has launched a one-of-a-kind retinal that is tolerated by all skin types. Retaxome is a Daily Retinal Hydrator that is setting a new gold standard in regenerative retinoid therapy. What makes Retaxome different is the way that it is delivered—encapsulated in an exosome, the delivery of the retinal is of a much greater potency. This allows for faster results and precise delivery while lessening the risk of irritation.
Another thing that makes Retaxome unique is the triple-action innovation that Hydrinity has developed. The biometric exosome infused with retinal enables precise cell-to-cell communication. The deeper delivery of the product, up to 20x deeper, allows you to get the results you are looking for quickly when used consistently. The retinal in this product is considered highly tolerable and indicated for nightly use from day one, while other retinal products require acclimation.
The last ingredient in Retaxome that makes it extremely tolerable and efficient is the supercharged HA in the product. It is formulated with 100% injectable-grade dual-weight hyaluronic acid. This allows for deep hydration to balance the skin and prevent unwanted reactions. In a recent multi-center open enrollment study, 100% of patients said Retaxome did not cause their skin to be irritated, red, or inflamed. 95% of patients said they were able to use the product when they were previously unable to tolerate other retinoid products. Studies also show a 44% increase in skin hydration from baseline at 2 weeks.
References:
MedPath – Medical Intelligence Platform. (2025, September 10). MedPath. https://trial.medpath.com/news/48a2c9f1563ec534/new-retinal-formulation-retaxome-shows-enhanced-tolerability-in-clinical-studies
Zheng, C., Xi, H., Wen, D., Ke, Y., Zhang, X., Ren, X., & Li, X. (2022). Biocompatibility and Efficacy of a Linearly Cross-Linked Sodium Hyaluronic Acid Hydrogel as a Retinal Patch in Rhegmatogenous Retinal Detachment Repairment. Frontiers in Bioengineering and Biotechnology, 10, 914675. https://doi.org/10.3389/fbioe.2022.914675
Megan Hand, FNP-C
Aesthetic Injector
REQUEST AN APPOINTMENT
At MELA Medical Spa, your journey towards beauty and wellness is just a step away. Schedule your appointment with us today and let our team of aesthetic experts create a personalized treatment plan tailored to your unique needs.
Follow us!
A new product has hit the market from one of the most scientific, clean skincare companies. Hydrinity has launched a one-of-a-kind retinal that is tolerated by all skin types. Retaxome is a Daily Retinal Hydrator that is setting a new gold standard in regenerative retinoid therapy. What makes Retaxome different is the way that it is delivered—encapsulated in an exosome, the delivery of the retinal is of a much greater potency. This allows for faster results and precise delivery while lessening the risk of irritation.
Another thing that makes Retaxome unique is the triple-action innovation that Hydrinity has developed. The biometric exosome infused with retinal enables precise cell-to-cell communication. The deeper delivery of the product, up to 20x deeper, allows you to get the results you are looking for quickly when used consistently. The retinal in this product is considered highly tolerable and indicated for nightly use from day one, while other retinal products require acclimation.
The last ingredient in Retaxome that makes it extremely tolerable and efficient is the supercharged HA in the product. It is formulated with 100% injectable-grade dual-weight hyaluronic acid. This allows for deep hydration to balance the skin and prevent unwanted reactions. In a recent multi-center open enrollment study, 100% of patients said Retaxome did not cause their skin to be irritated, red, or inflamed. 95% of patients said they were able to use the product when they were previously unable to tolerate other retinoid products. Studies also show a 44% increase in skin hydration from baseline at 2 weeks.
References:
MedPath – Medical Intelligence Platform. (2025, September 10). MedPath. https://trial.medpath.com/news/48a2c9f1563ec534/new-retinal-formulation-retaxome-shows-enhanced-tolerability-in-clinical-studies
Zheng, C., Xi, H., Wen, D., Ke, Y., Zhang, X., Ren, X., & Li, X. (2022). Biocompatibility and Efficacy of a Linearly Cross-Linked Sodium Hyaluronic Acid Hydrogel as a Retinal Patch in Rhegmatogenous Retinal Detachment Repairment. Frontiers in Bioengineering and Biotechnology, 10, 914675. https://doi.org/10.3389/fbioe.2022.914675
Megan Hand, FNP-C
Aesthetic Injector
REQUEST AN APPOINTMENT
At MELA Medical Spa, your journey towards beauty and wellness is just a step away. Schedule your appointment with us today and let our team of aesthetic experts create a personalized treatment plan tailored to your unique needs.